Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions

<p><strong>Objectives</strong> The Heart Protection Study (HPS) provides an opportunity to assess directly the effects of cholesterol-lowering therapy on major vascular events (defined as myocardial infarction, coronary death, stroke, or revascularization) in patients with peripher...

Полное описание

Библиографические подробности
Главный автор: Heart Protection Study Collaborative Group
Другие авторы: The Society for Vascular Surgery
Формат: Journal article
Язык:English
Опубликовано: Elsevier 2007
Предметы:

Схожие документы